BDBM50193901 7-(2,6-dimethylphenyl)-5-methyl-N-(3-(piperazin-1-ylsulfonyl)phenyl)benzo[e][1,2,4]triazin-3-amine::CHEMBL218049::US8481536, 422

SMILES Cc1cccc(C)c1-c1cc(C)c2nc(Nc3cccc(c3)S(=O)(=O)N3CCNCC3)nnc2c1

InChI Key InChIKey=OIWCCBCIMSSCLH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50193901   

TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Targegen

Curated by ChEMBL
LigandPNGBDBM50193901(7-(2,6-dimethylphenyl)-5-methyl-N-(3-(piperazin-1-...)
Affinity DataIC50:  480nMAssay Description:Inhibition of human recombinant Src kinaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Targegen

Curated by ChEMBL
LigandPNGBDBM50193901(7-(2,6-dimethylphenyl)-5-methyl-N-(3-(piperazin-1-...)
Affinity DataIC50:  48.2nMT: 2°CAssay Description:Testing of inhibition of kinases in vitro using luciferase-based assay from KinaseGlo, Promega Corp.More data for this Ligand-Target Pair
In DepthDetails US Patent